| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.9M | +337.4% |
| SG&A Expense | $2.5M | +20.8% |
| Operating Income | -$9.4M | -157.2% |
| Net Income | -$8.9M | -502.8% |
| EPS (Basic) | -$34.01 | — |
| EPS (Diluted) | -$34.01 | -9.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Current Assets | $3.7M | -56.0% |
| Total Assets | $3.7M | -56.0% |
| Current Liabilities | $831K | -67.4% |
| Total Liabilities | $831K | -67.4% |
| Stockholders' Equity | $2.9M | -51.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.6M | -167.9% |
| Financing Cash Flow | $5.0M | +13.9% |